BNO

Bionomics Limited

About BNO

Bionomics Limited (BNO) is a biopharmaceutical company leveraging its proprietary platform technologies to discover and develop a deep pipeline of novel drug candidates. Bionomics' lead drug candidate BNC210 is a novel, proprietary negative allosteric modulator of the alpha-7 (7) nicotinic acetylcholine receptor. Beyond BNC210, Bionomics has a strategic partnership with Merck & Co., Inc and a pipeline of pre-clinical ion channel programs targeting pain, depression, cognition and epilepsy

Buy Australian shares starting with BNO. Invest today with a CHESS-sponsored broker!

Sector

Health Care

CEO

Industry

Biotechnology

Website

bionomics.com.au

Market Capitalisation

$34M

Price-earnings ratio

-1.43

Dividend yield

0.00%

High today

$0.02

Low today

$0.02

Open price

$0.02

52-week high

$0.07

52-week low

$0.02

Announcements

BNO FAQs

How much is one share of Bionomics Limited?

One share of Bionomics Limited is valued at $0.02.

What is the ticker symbol for Bionomics Limited?

The ticker symbol for Bionomics Limited is BNO.

How do I buy BNO shares in Australia?

To buy BNO stocks in Australia you'll need to open an account with a broker like Stake.
To do so follow these steps:

Sign up in minutes, all you need is some I.D.
Choose Stake AUS
Deposit directly into your Stake wallet and you're ready to invest in BNO

What is the 52-week high for Bionomics Limited stock?

The Bionomics Limited 52-week high stock price is $0.07.

What is the 52-week low for Bionomics Limited stock?

The Bionomics Limited 52-week low stock price is $0.02.

What is the market capitalisation of Bionomics Limited BNO?

As of 24/03/2023 Bionomics Limited has a market cap of $34M.

Related Stocks

This does not constitute financial advice. You should do your own research before making an investment decision. Past performance is not a reliable indication of future performance. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.